Logo

Aurora Spine Receives the US FDA’s Clearance for ZIP MIS Implant Device to Treat Lumbar Spinal Stenosis

Share this
Aurora Spine Receives the US FDA’s Clearance for ZIP MIS Implant Device to Treat Lumbar Spinal Stenosis

Aurora Spine Receives the US FDA’s Clearance for ZIP MIS Implant Device to Treat Lumbar Spinal Stenosis

Shots:

  • The company received the US FDA clearance for the ZIP MIS interspinous fusion system, a non-pedicle supplemental fixation device as a new lumbar spinal stenosis indication. Numerous bone anchors, Aurora Spine's revolutionary one-step locking mechanism without a set screw, and a sizable graft space intended for biologic materials are all included in the ZIP line of implants
  • The device fills the gap b/w traditional fusion surgery and other conservative interventional methods by providing a minimally invasive approach to treating a wider range of patients
  • The ZIP product line was developed as an alternative to pedicle screw fixation. The ZIP MIS interspinous fusion system should only be used in conjunction with bone transplant material

Ref: Globenewswire | Image: Aurora Spine 

Click here to­ read the full press release 

Neha

Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions